Post Categories
They’ve been so popular in the US that QPS is bringing our educational seminars to Europe! Join the QPS Education Seminar Germany on September 15th in the Munich area.
September 3, 2015
The focus of this seminar is on increasing the success of Biotech. Participation is free of charge. When and where: September 15th, 2015 16:00…
Finance Monthly Honors QPS for Success, Motivation and Strategic Vision
September 1, 2015
CEO Award an indicator of company-wide hard work and inspiration QPS Holdings, LLC, a leading full-service GLP/GCP-compliant contract research organization providing testing services to…
Attention All Hepatocyte Fanatics!
August 31, 2015
It’s time to register for the Hepatocyte Research Association (HRA) 11th Annual Meeting at ISSX Orlando: October 20, 2015 2pm – 6pm Hilton Orlando…
Specialized, Collaborative Clinical Development Services Provide Peace of Mind for Clients
August 18, 2015
Okay, we’ll admit it: a company telling you about their new brochure seems about as interesting as looking through your Great Uncle’s vacation pictures…
First-in-Human, Safety, Tolerability, PK and PD Study of a Rapid Onset Anesthetic: QPS Plays It Safe!
August 28, 2015
QPS was able to deliver on this extremely challenging early phase clinical trial because we have access to the expertise of a university anaesthesiology…
Writing the Book on Beta-Alanine for Sports Performance: QPS MRA’s Doug Kalman Takes a Stand
August 11, 2015
Ever wish that really big hill you always cycle up would seem a little less hilly? Want to swing impressive poundage at your next…
QPS Aids Development of Cannabinoid Chewing Gum, for MS Patients
August 11, 2015
Cannabinoid bioscience has come a long way. New York-based Axim Biotech is at the forefront, developing – among many other, related products – a…
Mental Vacation
August 11, 2015
Need a vacation? Don’t have time? Spend the next 45 seconds pretending you’re here….
Fast Track Routes for Medicines that address Unmet Medical Needs
July 27, 2015
Launch of two-month public consultations on revised guidelines on accelerated assessment and conditional marketing authorization The European Medicines Agency (EMA) has revised its guidelines…
Sports Nutrition Leadership, Benchtop to Countertop: Watch the Webinar on Building Better Beverages with panelist Doug Kalman, Director of Nutrition & Endocrinology at QPS MRA
July 29, 2015
Finding something tasty to drink at the mini-mart has gotten really complicated lately. Knowing the usual soft drinks are unhealthy, you may be tempted…
DMPK scientists from Exelixis and QPS publish on “Metabolism and Disposition of Cabozantinib in Healthy Male Volunteers and Pharmacologic Characterization of Its Major Metabolites” in DMD
July 27, 2015
Read the original Exelexis-supported publication in Drug Metabolism & Disposition (DMD). Cabozantinib (COMETRIQ®) inhibits the activity of tyrosine kinases including MET, VEGFRs and RET….
Dr. Diane Krieger from QPS MRA acknowledged in NEJM for her role as investigator in the SCALE Obesity and Prediabetes Study Group
July 27, 2015
The sheer abundance of diet drugs available suggests two things: 1) there is a huge market for them and 2) none of them work…
From Shark Tank to Pharmaceuticals: Billionaire Mark Cuban Makes a Leap for Affordable Medicines
April 4, 2022
Mark Cuban is spearheading an effort to widen Americans’ access to generic pharmaceuticals, adding a direct-to-consumer online pharmacy to the Mark Cuban Cost Plus…
How Can Guidelines Keep Pace with Science? “Living Evidence” May Help
March 28, 2022
Traditionally, the review and updating of medical guidelines have relied on a “systematic review” – a publication following a formal synthesis of data from…
New Draft FDA Guidance on ADC Pharmacology
March 23, 2022
The market for antibody-drug conjugates, or ADCs, is hotter than ever before. In response, the Food and Drug Administration (FDA) released new guidance on clinical…
Lilly/Entos Deal Reinforces the Significance of Delivery Mechanisms for Nucleic Acid-Based Therapies
March 21, 2022
As part of a research partnership aimed at improving the delivery of nucleic acid-based therapies targeting nervous system diseases, American pharmaceutical company Eli Lilly…
Gene Deserts May Hold an Oasis — a Cure for HIV
March 14, 2022
In human cells infected by the human immunodeficiency virus (HIV), virus particles can leave behind part of their genetic material, which gets incorporated into…
New AstraZeneca Drug for HER2-Low Breast Cancer Aces Phase III Trial
March 9, 2022
Infographics Not all cancer cases are created equal. As the medical community hones in on better, less invasive cancer treatments, differentiating between different types…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
QPS India has achieved another significant milestone by successfully completing a scheduled inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) from…
QPS Selects Ryght AI as an Exclusive AI Partner for Clinical Trial Optimization and Automation while adding to Ryght’s global site network. Laguna Beach,…
